Feedback / Questions
CHS-0214 (etanercept biosimilar) - Coherus
Daiichi Sankyo: Q2 FY 2016 Results
(Daiichi Sankyo)
-
Nov 5, 2016 -
Anticipated regulatory submission in Japan for RA in FY2016
Anticipated Japanese regulatory
•
Biosimilar
http://www.daiichisankyo.com/media_investors/investor_relations/ir_calendar/files/005322/Presentation%20Material.pdf
Nov 5, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious